Zobrazeno 1 - 10
of 50
pro vyhledávání: '"M, de Weers"'
Publikováno v:
Clinical Genetics. 48:46-48
A 13-year-old boy with immunodeficiency with hyper-IgM was analyzed for mutations in the CD40L gene. An insertional mutation of an extra T in a run of four T's was found in the second exon of the gene, leading to a premature translation stop. Genetic
Autor:
Ruud K. B. Schuurman, Rudolf W. Hendriks, Gaby S. Brouns, Christine Kinnon, Jannie Borst, S. Hinshelwood, M. De Weers
Publikováno v:
Journal of Biological Chemistry. 269:23857-23860
X-linked agammaglobulinemia (XLA) is an inherited human immunodeficiency disease, characterized by an arrest in B-cell development, which results in a dramatic decrease in immunoglobulin production. The gene product defective in XLA has been identifi
Autor:
Christian Kellner, Martin Gramatzki, Thomas Valerius, Matthias Staudinger, Roland Repp, Pia Glorius, Paul W. H. I. Parren, Matthias Peipp, Daniela Hallack, M de Weers, Andreas Humpe, S Mohseni Nodehi, M Stauch, J.G.J. van de Winkel
Publikováno v:
Leukemia. 26(4)
Fusion proteins between ligands for NKG2D and CD20-directed single-chain variable fragments sensitize lymphoma cells for natural killer cell-mediated lysis and enhance antibody-dependent cellular cytotoxicity
Autor:
Paul W. H. I. Parren, Shulamiet Wittebol, Joost M. Bakker, H M Lokhorst, M de Weers, Tuna Mutis, M S van der Veer, B van Kessel
Publikováno v:
Blood cancer journal, 1(10):e41. Nature Publishing Group
Van Der Veer, M S, De Weers, M, Van Kessel, B, Bakker, J M, Wittebol, S, Parren, P W H I, Lokhorst, H M & Mutis, T 2011, ' The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies ', Blood cancer journal, vol. 1, no. 10, e41 . https://doi.org/10.1038/bcj.2011.42
Blood Cancer Journal
Van Der Veer, M S, De Weers, M, Van Kessel, B, Bakker, J M, Wittebol, S, Parren, P W H I, Lokhorst, H M & Mutis, T 2011, ' The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies ', Blood cancer journal, vol. 1, no. 10, e41 . https://doi.org/10.1038/bcj.2011.42
Blood Cancer Journal
Multiple myeloma (MM) is an incurable malignancy of antibody-producing clonal plasma cells. The mean life expectancy of patients has remained at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::362c3343e92cc1c4b33187fcea0b73e7
https://research.vumc.nl/en/publications/c4aa3507-e860-4e03-b425-a07b3deb058f
https://research.vumc.nl/en/publications/c4aa3507-e860-4e03-b425-a07b3deb058f
Publikováno v:
Clinical Immunology and Immunopathology. 61:S83-S93
X-linked agammaglobulinemia (XLA) patients manifest a very low production of immunoglobulins (Ig) of all classes and plasma cells are virtually absent. The XLA gene plays a crucial role in the transition of pre-B cells to later B cell stages, as hard
Autor:
Ruth C. Lovering, Rob G.J. Mensink, Gaby S. Brouns, M. De Weers, Ruud K. B. Schuurman, Margriet E. M. Kraakman, Rudolf W. Hendriks, Jannie Borst, G. M. Dingjan
Publikováno v:
Clinical and experimental immunology. 107(2)
SUMMARY X-linked agammaglobulinaemia (XLA) is an immunodeficiency caused by mutations in Bruton's tyrosine kinase (Btk) and is characterized by an almost complete arrest of B cell development. We analysed expression of Btk in B lymphoblastoid cell li
Publikováno v:
The Journal of biological chemistry. 269(39)
X-linked agammaglobulinemia (XLA) is an inherited human immunodeficiency disease, characterized by an arrest in B-cell development, which results in a dramatic decrease in immunoglobulin production. The gene product defective in XLA has been identifi
Autor:
Rob G.J. Mensink, M. De Weers, Ruud K. B. Schuurman, Margriet E. M. Kraakman, Rudolf W. Hendriks
Publikováno v:
Human molecular genetics. 3(1)
X-linked agammaglobulinemia (XLA) is an inherited immunodeficiency disease in man, reflecting an arrest in differentiation of pre-B cells to mature B cell stages. The gene defective in XLA has been identified as a cytoplasmic protein tyrosine kinase,
Autor:
M de Weers, Berris van Kessel, Shulamiet Wittebol, Tuna Mutis, Paul Parren Parren, M S van der Veer, H M Lokhorst, Joost M. Bakker
Publikováno v:
Journal of Clinical Oncology. 29:e18571-e18571
e18571 Background: Multiple myeloma (MM) represents an incurable malignancy of antibody-producing clonal plasma cells. Over the past decade significant progress has been made in MM treatment using ...
Publikováno v:
Human immunology. 36(4)
Mhc-DRB and -DQA1 second-exon and -DRB 3'-untranslated-region nucleotide sequences of three lowland gorillas with no known family relationship with each other and of two HLA homozygous typing cell lines were determined and compared with published pri